Literature DB >> 17264460

Bronchopulmonary dysplasia: an update.

Anita Bhandari1, Vineet Bhandari.   

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic lung disease associated with premature birth and characterized by early lung injury. Over the past 4 decades, there have been significant changes in its definition, pathology and radiological findings as well as management of BPD. Management of the acute phase and later stages of this lung disease continue to evolve. Use of non-invasive ventilatory techniques, recombinant human SOD and CC10 and inhaled NO are some novel approaches that are being studied. Adequate nutrition is vital to optimize lung growth and repair. The widely accepted practice of prophylaxis against viral infections has markedly decreased the rates of rehospitalization. Infants with BPD, however, continue to have significant pulmonary and neurodevelopmental sequelae. Unraveling the genetic contribution to BPD will potentially pave the way to improved preventive and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264460     DOI: 10.1007/s12098-007-0032-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  42 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  Hyaline membrane disease and a related spectrum of neonatal pneumopathies.

Authors:  R C Rosan
Journal:  Perspect Pediatr Pathol       Date:  1975

3.  The safety and efficacy of nitric oxide therapy in premature infants.

Authors:  J M Hascoet; J Fresson; O Claris; I Hamon; J Lombet; A Liska; S Cantagrel; J Al Hosri; G Thiriez; V Valdes; G Vittu; L Egreteau; A Henrot; M C Buchweiller; P Onody
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

4.  Potential biochemical growth markers in premature infants.

Authors:  V Bhandari; P Fall; L Raisz; J Rowe
Journal:  Am J Perinatol       Date:  1999       Impact factor: 1.862

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

6.  The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.

Authors:  Carolyn R Levine; Ira H Gewolb; Kristen Allen; Richard W Welch; James M Melby; Simcha Pollack; Thomas Shaffer; Aprile L Pilon; Jonathan M Davis
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

7.  Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).

Authors:  D Field; D Elbourne; A Truesdale; R Grieve; P Hardy; A C Fenton; N Subhedar; J Ahluwalia; H L Halliday; J Stocks; K Tomlin; C Normand
Journal:  Pediatrics       Date:  2005-04       Impact factor: 7.124

8.  Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes.

Authors:  Elizabeth J Short; Nancy K Klein; Barbara A Lewis; Sarah Fulton; Sheri Eisengart; Carolyn Kercsmar; Jill Baley; Lynn T Singer
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

9.  Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.

Authors:  H Verder; P Albertsen; F Ebbesen; G Greisen; B Robertson; A Bertelsen; L Agertoft; B Djernes; E Nathan; J Reinholdt
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

10.  Speech and language outcomes of children with bronchopulmonary dysplasia.

Authors:  Barbara A Lewis; Lynn T Singer; Sarah Fulton; Ann Salvator; Elizabeth J Short; Nancy Klein; Jill Baley
Journal:  J Commun Disord       Date:  2002 Sep-Oct       Impact factor: 2.288

View more
  12 in total

1.  Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials.

Authors:  Lisa M Askie; Roberta A Ballard; Gary R Cutter; Carlo Dani; Diana Elbourne; David Field; Jean-Michel Hascoet; Anna Maria Hibbs; John P Kinsella; Jean-Christophe Mercier; Wade Rich; Michael D Schreiber; Pimol Srisuparp Wongsiridej; Nim V Subhedar; Krisa P Van Meurs; Merryn Voysey; Keith Barrington; Richard A Ehrenkranz; Neil N Finer
Journal:  Pediatrics       Date:  2011-09-19       Impact factor: 7.124

Review 2.  Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook.

Authors:  Laura Cerny; John S Torday; Virender K Rehan
Journal:  Lung       Date:  2008-01-30       Impact factor: 2.584

3.  Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.

Authors:  Jasmine Sahni; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

Review 4.  Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis.

Authors:  Lisa M Askie; Roberta A Ballard; Gary Cutter; Carlo Dani; Diana Elbourne; David Field; Jean-Michel Hascoet; Anna Maria Hibbs; John P Kinsella; Jean-Christophe Mercier; Wade Rich; Michael D Schreiber; Pimol Srisuparp; Nim V Subhedar; Krisa P Van Meurs; Merryn Voysey; Keith Barrington; Richard A Ehrenkranz; Neil Finer
Journal:  BMC Pediatr       Date:  2010-03-23       Impact factor: 2.125

5.  Hyperoxia and interferon-γ-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway.

Authors:  Rayman Choo-Wing; Mansoor A Syed; Anantha Harijith; Brianne Bowen; Gloria Pryhuber; Cecilia Janér; Sture Andersson; Robert J Homer; Vineet Bhandari
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

6.  Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia.

Authors:  Li Pan; Jian-Hua Fu; Xin-Dong Xue; Wei Xu; Ping Zhou; Bing Wei
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

7.  Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes.

Authors:  Vineet Bhandari; Neil N Finer; Richard A Ehrenkranz; Shampa Saha; Abhik Das; Michele C Walsh; William A Engle; Krisa P VanMeurs
Journal:  Pediatrics       Date:  2009-07-27       Impact factor: 7.124

8.  Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn.

Authors:  Sachin Gupta; Kaninghat Prasanth; Chung-Ming Chen; Tsu F Yeh
Journal:  Int J Pediatr       Date:  2011-10-04

9.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia.

Authors:  Alecia Thompson; Vineet Bhandari
Journal:  Biomark Insights       Date:  2008-07-02

Review 10.  Targeting mitochondrial dysfunction in lung diseases: emphasis on mitophagy.

Authors:  Angara Sureshbabu; Vineet Bhandari
Journal:  Front Physiol       Date:  2013-12-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.